🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a Phase 1, single-center, open-label, single-dose study to ev...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2006-03
Trial ID
NCT03202693
Treatments Being Tested
The trial will evaluate the extended bactericidal activity of 14 consecutiv...
Status
Completed
Location
Centre for Tuberculosis Research Innovation, UCT Lung Institute
Start Date
2012-10
Trial ID
NCT01691534
Treatments Being Tested
To evaluate the efficacy, safety and tolerability of various doses and dura...
Status
Completed
Location
National Center for Tuberculosis and Lung Diseases
Start Date
2017-11-21
Trial ID
NCT03086486
Treatments Being Tested
The goal of this clinical trial is to evaluate 3 dose levels of TBAJ876 for...
Status
Active Not Recruiting
Location
National Center for Tuberculosis and Lung Diseases
Start Date
2023-10-31
Trial ID
NCT06058299
Treatments Being Tested
The purpose of this study is to assess the mycobactericidal activity of the...
Status
Completed
Location
Task Applied Science, Karl Bremer Hospital
Start Date
2012-03
Trial ID
NCT01498419
Treatments Being Tested
The trial will evaluate the extended bactericidal activity of 14 consecutiv...
Status
Completed
Location
Centre for Tuberculosis Research Innovation, UCT Lung Institute
Start Date
2010-10
Trial ID
NCT01215851
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety, tolerability...
Status
Completed
Location
Task Applied Science - Brooklyn Chest Hospital
Start Date
2015-03
Trial ID
NCT02333799
Treatments Being Tested
Pretomanid is being used in an antimicrobial combination regimen(s) to trea...
Status
Completed
Location
National Center for Tuberculosis and Lung Diseases
Start Date
2021-09-16
Trial ID
NCT04179500
Treatments Being Tested
To evaluate the efficacy, safety and tolerability at 8 weeks (2-months), 52...
Status
Completed
Location
Evandro Chagas
Start Date
2018-07-30
Trial ID
NCT03338621
Treatments Being Tested